Plasmavigilance—Adverse events among US Source plasma donors-Reference-Cited by-同舟云学术

Plasmavigilance—Adverse events among US Source plasma donors

Published:2021-08-14 Issue:10 Volume:61 Page:2941-2957
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Schreiber George B.¹^ORCID,Becker Mark²,Fransen Michelle¹,Hershman Janet³,Lenart James³,Song Guang⁴,Simon Toby⁵

Affiliation:

1. Plasma Protein Therapeutics Association Annapolis Maryland USA

2. Biomat USA, Inc Seattle Washington USA

3. Takeda/BioLife Plasma Services LP Bannockburn Illinois USA

4. FEI Systems Columbia Maryland USA

5. CSL Plasma Boca Raton Florida USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16612

Reference24 articles.

1. Plasma Protein Therapeutics Association(2020). Current members. Plasma Protein Therapeutics Association. Available from:https://www.pptaglobal.org/about-us/current-members. Accessed Jul 13 2020.

2. Donor hemovigilance: a call to arms

3. Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey

4. The safety profile of automated collections: an analysis of more than 1 million collections

5. Complications of donor apheresis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large‐scale real‐world data analysis of source plasma collections using a novel technology‐enabled nomogram;Transfusion;2023-10-15

2. A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis;Vox Sanguinis;2023-08-29

3. Why do US source plasma donors stop donating?;Transfusion;2023-08-25

4. Effects of donation frequency on U.S. source plasma donor health;Transfusion;2023-08-25

5. Development and validation of a nomogram for predicting the risk of vasovagal reactions after plasma donation;Journal of Clinical Apheresis;2023-07-19